Les enjeux de la surcharge hydro-sodée

Nephrol Ther. 2016 Dec;12(7S):S10-S11. doi: 10.1016/S1769-7255(17)30020-2.
[Article in French]
No abstract available

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Blood Volume
  • Clinical Trials as Topic
  • Extracellular Fluid
  • Humans
  • Hypertension / etiology
  • Hypertension / prevention & control
  • Hypertrophy, Left Ventricular / etiology
  • Hypertrophy, Left Ventricular / prevention & control
  • Hypotension / etiology
  • Hypotension / prevention & control
  • Practice Guidelines as Topic
  • Renal Dialysis / adverse effects*
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology
  • Sodium / administration & dosage
  • Sodium / adverse effects
  • Water Intoxication / etiology
  • Water Intoxication / prevention & control
  • Water-Electrolyte Imbalance / etiology*
  • Water-Electrolyte Imbalance / physiopathology
  • Water-Electrolyte Imbalance / prevention & control

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Sodium